Indeed, strategies aimed to restore PTEN expression/activity with inhibition of IKK/NF-κB and mTOR signaling in injured hepatocytes might counteract hepatic IR, steatohepatitis and potentially more serious liver diseases for prolonged survival [14,30]. This evidence concerns the gene NFKB1 and liver disorder.